Patients Taking Anti-Osteoporosis Medication 52 Weeks After the Sentinel Fracture
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Percentage of patients still taking anti-osteoporosis medication (AOM) 52 weeks after the date of sentinel fracture.
Numerator
Number of patients still taking AOM 52 weeks after the date of sentinel fracture
Denominator
Number of patients with a treatment recommendation to start AOM or referred to general practitioner (GP) or referred to another clinician minus patients who have died
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Extracted from FLSDB
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, et al. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. 2020;31(7):1193-204.
Technical Specifications
Original paper. link.springer.com/article/10.1007/s00198-020-05377-1